Suppr超能文献

用于阿尔茨海默病早期谱系纵向研究的 UPSA 简短形式的开发。

Development of an UPSA Short Form for Use in Longitudinal Studies in the Early Alzheimer's Disease Spectrum.

机构信息

Dr. Jesus J. Gomar, Litwin-Zucker Alzheimer's Disease Center, Feinstein Institute, Manhassett, NY, USA, Email:

出版信息

J Prev Alzheimers Dis. 2020;7(3):179-183. doi: 10.14283/jpad.2019.51.

Abstract

BACKGROUND

In individuals with only mild or very mild cognitive attenuations (i.e., so-called pre-clinical AD), performance-based measures of function may be superior to informant-based measures because of increased sensitivity, greater reliability, and fewer ceiling effects.

OBJECTIVE

We sought to determine if a performance-based measure of everyday function would demonstrate adequate psychometric properties and validity in the context of serial assessment over a one-year period in patients with Mild Cognitive Impairment (MCI) and early stage Alzheimer's disease (AD).

DESIGN

Participants were assessed with the performance-based measure at baseline, six weeks, and one year.

SETTING

A specialized center for the assessment and treatment of AD.

PARTICIPANTS

Three groups of subjects participated: a healthy subjects (HS) older cognitively intact group (N=43), an MCI group (N=20), and an AD group (N=26).

MEASUREMENTS

A three subtest short form of the UCSD Performance-Based Skills Assessment (UPSA) (called the UPSA-3) was the measure of interest. It consisted of the Communication, Planning, and Finance subtests.

RESULTS

Mixed model repeated measures were used to assess performance over time. Large group effects were present (HS>MCI>AD). Additionally, the AD and MCI groups demonstrated declines over one year, while the HS group remained stable (group x time interaction p=.11). The MCI/AD group demonstrated adequate test-retest reliability and did not demonstrate ceiling or floor effects.

CONCLUSION

Our data indicate that the UPSA-3 is suitable for clinical trials in that it has adequate ecological coverage and reasonable psychometric properties, and perhaps most importantly, demonstrates validity in serial assessments.

摘要

背景

在仅有轻度或非常轻度认知障碍(即所谓的临床前 AD)的个体中,基于表现的功能评估可能优于基于知情者的评估,因为前者具有更高的敏感性、更强的可靠性和更少的天花板效应。

目的

我们旨在确定在轻度认知障碍(MCI)和早期阿尔茨海默病(AD)患者的一年连续评估中,基于表现的日常功能评估是否具有足够的心理测量学特性和有效性。

设计

参与者在基线、6 周和 1 年均接受基于表现的评估。

地点

AD 评估和治疗的专门中心。

参与者

三组受试者参与:一组认知正常的健康受试者(HS)(N=43),一组 MCI 组(N=20),一组 AD 组(N=26)。

测量

UCSD 基于表现的技能评估(UPSA)的三个子测试短形式(称为 UPSA-3)是感兴趣的测量方法。它包括沟通、规划和财务三个子测试。

结果

混合模型重复测量用于评估随时间的表现。存在较大的组间效应(HS>MCI>AD)。此外,AD 和 MCI 组在一年内表现出下降,而 HS 组保持稳定(组间时间交互作用 p=.11)。MCI/AD 组表现出足够的测试-重测可靠性,并且没有表现出天花板或地板效应。

结论

我们的数据表明,UPSA-3 适合临床试验,因为它具有足够的生态覆盖范围和合理的心理测量学特性,也许最重要的是,在连续评估中表现出有效性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验